Monitored Therapeutics builds remote patient monitoring hardware and software for respiratory conditions, including the GoSpiro handheld Bluetooth spirometer (FDA 501(k) cleared in 2017) and the GoHome patient health monitor. The company also offers the GoClinic platform for in-clinic use and pharmaceutical clinical trials. MTI says it is revenue-generating and currently serves five of the top ten respiratory hospitals in the United States. Its products target COPD, asthma, lung transplant and cystic fibrosis populations and aim to enable lab-quality monitoring at home. MTI plans to scale into the broader respiratory patient population and expand its position in decentralized pharmaceutical clinical trials, a market accelerated by COVID-19. The company emphasizes increasing patient engagement and drug adherence while reducing healthcare costs by keeping patients at home.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2021